medigraphic.com
SPANISH

Revista Biomédica

Centro de Investigaciones Regionales Dr. Hideyo Noguchi, Universidad Autónoma de Yucatán
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2025, Number 2

<< Back Next >>

Rev Biomed 2025; 36 (2)

Urinary tract infection and septicemia by Yersinia frederiksenii in a patient with multiples comorbidities. Case report

Mendoza-Perez VS, Becerril-Flores MA, Prieto-Hernández GJ, Palma-Antonio CL, Perez-Perusquia MC
Full text How to cite this article

Language: Spanish
References: 10
Page: 50-54
PDF size: 91.39 Kb.


Key words:

Yersinia frederiksenii, Kidney failure, Septicemia, Hemodialysis, Sepsis.

ABSTRACT

Introduction. Yersinia frederiksenii is a bacterium that can cause intestinal infections in humans and rarely extraintestinal infections. Yersinia frederiksenii has been isolated from stool samples and lessly from blood and sputum.
Clinical Case. A case of a 73-year-old male is reported who had a urinary tract infection and who, after his hospitalization, developed sepsis where Yersinia frederiksenii was isolated from biological samples of urine and blood, requiring management. in emergency room and internal medicine services. As a background, the patient presented infection of hemodialysis catheter confirmed by Pseudomonas aeruginosa and Staphylococcus aureus receiving pharmacological treatment erradicating the presence of both patogens. The patient’s evolution was unsatisfactory, leading to death despite antimicrobial treatment.
Discussion. The immunosuppression presented by the patient facilitated the infection by Yersinia frederiksenii. Recommendations for diagnostic and treatment are made. The present case is the first report of urosepsis caused by Yersinia frederiksenii.


REFERENCES

  1. Springer K, Sänger P-A, Moritz C, Felsl A, Rattei T andFuchs. Insecticidal Toxicity of Yersinia frederikseniiInvolves the Novel Enterotoxin. YacT. Front. Cell.Infect. Microbiol. 2018 Nov; 8 (1):1-12.

  2. Yeung E. A Case Series of Diarrheal Diseases Associatedwith Yersinia frederiksenii. Infect Dis Rep. 2021 Jun13;13(2):552-57.

  3. Merck Manual Plague and Other Yersinia Infections[Internet]. 2022 [cited 2024 May 18]; Available from:https://www.merckmanuals.com/enca/professional/infectiousdiseases/gram-negativebacilli/plague-andother-yersinia-infections

  4. Bottone EJ. Yersinia enterocolitica: the charismacontinues. Clin Microbiol Rev. 1997 Apr;10(2):257-76.

  5. Ursing J, Don Brennert J, Bercovier H, Richard FanningG, G. Steigerwal, A, Brault J, et al. Yersinia frederiksenii:A new species of enterobacteriaceae composed ofrhamnose positive strains (formerly called atypicalyersinia enterocolitica or Yersinia enterocolitica Like).Curr microbiology. 1980 Jul; 4 (4): 213-7

  6. Goullet P, Picard B. Characterization of Yersiniaenterocolitica, Y. intermedia, Y. aldovae, Y.frederiksenii, Y. kristensenii and Y. pseudotuberculosisby electrophoretic polymorphism of acid phosphatase,esterases, and glutamate and malate dehydrogenases. JGen Microbiol. 1988 Feb; 134(2):317-325.

  7. Zexun Lü, Li Su, Mengting Han, Xiaoqi Wang, Mei Li,Siyue Wang, et al. Genomic characteristics and virulenceof common but overlooked Yersinia intermedia, Y.frederiksenii, and Y. kristensenii in food. Int Journal ofFood Micro. 2025, Feb; 430(1): 1-15

  8. Pascual, Lourdes I; Favier, Gabriela I; Iriarte Hebe J;Arismendi Sosa A; Mattar Dominguez. Bacteriocinasde Yersinia sp: obtención y evaluación de su efectoantimicrobiano. Universidad Nacional de Misiones

  9. Fàbrega A, Vila J. Yersinia enterocolitica: pathogenesis,virulence and antimicrobial resistance. Enferm InfeccMicrobiol Clin. 2012 Jan;30(1):24-32.

  10. García Cañete P. Ventajas y problemas de los métodosautomatizados de estudio de susceptibilidad in vitro.Rev. chil. infectol. 2002; 19 (2): 96-100.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Biomed. 2025;36